Found 8 matching trials
Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP
NAThe aim of the study is to compare the efficacy and safety of r-hFSH+r-hLH ...
Location
Centro Riproduzione e Andrologia
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
PHASE1The purpose of this study is to assess the Pharmacokinetic (PK) of Recombin...
Location
Fortrea Clinical Research Unit Ltd
Bioequivalence Trial of Liquid Versus Freeze-Dried Pergoveris® in Pituitary Suppressed Healthy Premenopausal Female Subjects
PHASE1Some women cannot have children because they cannot produce enough follicle...
Location
Please contact the Merck KGaA Communication Center
A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)
N/AThis prospective study collected safety information from more than 600 part...
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
PHASE3This is a multicenter, multi-national, randomized, open-label comparative t...
Ovarian Hyperstimulation and Fibrin Clot Properties.
NAThe impact evaluation of ovarian hyperstimulation on coagulation and fibrin...
Location
Department of Gynecological Endocrinology Jagiellonian University Medical College
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
PHASE3This is a Phase 3, randomized, controlled, single-blind, multicenter, paral...
Location
Please contact the Merck KGaA Communication Center
PErsonalized Addition of Recombinant LH in Ovarian Stimulation
PHASE4Different ovarian stimulation regimens have shown to modify late follicular...
Location
Hospital Universitario Quiron Dexeus